US regulator approves at-home Alzheimer’s drug from Eisai and Biogen
Go ahead for Leqembi shot by Food and Drug Administration could help revive two companies’ sluggish sales
Full Article
US regulator approves at-home Alzheimer’s drug from Eisai and Biogen
FT.com
0 shares
1 views